Healthcare-associated ventriculitis and meningitis (IDSA 2017): Difference between revisions
From IDWiki
m (Aidan moved page IDSA Healthcare-associated ventriculitis and meningitis 2017 to Healthcare-associated ventriculitis and meningitis (IDSA 2017) without leaving a redirect) |
mNo edit summary |
||
Line 3: | Line 3: | ||
<blockquote>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR. [https://doi.org/10.1093/cid/ciw861 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis]. ''Clin Infect Dis''. 2017. |
<blockquote>Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR. [https://doi.org/10.1093/cid/ciw861 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis]. ''Clin Infect Dis''. 2017. |
||
</blockquote> |
</blockquote> |
||
= Signs and Symptoms = |
|||
== Ventriculoperitoneal/ventriculopleural shunts == |
|||
* Headache, nausea, lethargy, or altered mental status |
* Headache, nausea, lethargy, or altered mental status |
||
Line 15: | Line 15: | ||
* Glomerulonephritis |
* Glomerulonephritis |
||
== External ventricular drains (EVD) == |
|||
* New or worsening mental status |
* New or worsening mental status |
||
* New fever and increased CSF white cell count |
* New fever and increased CSF white cell count |
||
== Head trauma == |
|||
* New headache, fever, meningeal irritation, seizures, or worsening mental status |
* New headache, fever, meningeal irritation, seizures, or worsening mental status |
||
* Fever without a focus |
* Fever without a focus |
||
== Intrathecal infusion pumps == |
|||
* New fever and drainage from the surgical site |
* New fever and drainage from the surgical site |
||
= CSF Findings = |
|||
== Basic chemistry == |
|||
* Cell count, glucose, and protein |
* Cell count, glucose, and protein |
||
Line 37: | Line 37: | ||
* False positives, and false normals |
* False positives, and false normals |
||
== Cultures == |
|||
* Culture the CSF! And probably blood (especially if ventriculoatrial) |
* Culture the CSF! And probably blood (especially if ventriculoatrial) |
||
Line 44: | Line 44: | ||
* Try to obtain cultures before antibiotics, if safe |
* Try to obtain cultures before antibiotics, if safe |
||
== Neurosurgery or head trauma == |
|||
* Elevated cell count, positive culture, and symptoms of infection indicate ventriculitis or meningitis |
* Elevated cell count, positive culture, and symptoms of infection indicate ventriculitis or meningitis |
||
Line 53: | Line 53: | ||
* Fungal cultures positive indicate infection |
* Fungal cultures positive indicate infection |
||
== Specific tests == |
|||
* CSF lactate or procalcitonin may be useful |
* CSF lactate or procalcitonin may be useful |
||
Line 60: | Line 60: | ||
* β-D-glucan and galactomannan may be helpful for fungal infections |
* β-D-glucan and galactomannan may be helpful for fungal infections |
||
= Imaging = |
|||
* MRI with gad and DWI is best |
* MRI with gad and DWI is best |
||
* If VP shunt and abdo symptoms, get abdo US or CT |
* If VP shunt and abdo symptoms, get abdo US or CT |
||
= Antimicrobials = |
|||
== Empiric regimens == |
|||
* Vanco for gram positives plus anti-pseudomonal beta-lactam (cefipime, ceftazidime, or meropenem) for gram negatives |
* Vanco for gram positives plus anti-pseudomonal beta-lactam (cefipime, ceftazidime, or meropenem) for gram negatives |
||
Line 73: | Line 73: | ||
* Second-line agents for gram-negative coverage include aztreonam and ciprofloxacin |
* Second-line agents for gram-negative coverage include aztreonam and ciprofloxacin |
||
== Specific regimens == |
|||
* Staphylococci |
* Staphylococci |
||
Line 95: | Line 95: | ||
** ''Aspergillus'' and ''Exserohilum'': voriconazole |
** ''Aspergillus'' and ''Exserohilum'': voriconazole |
||
== Intraventricular therapy == |
|||
* Should be considered if poor response to systemic therapy |
* Should be considered if poor response to systemic therapy |
||
Line 101: | Line 101: | ||
* Adjust dose based on MIC (target 10-20 times the MIC), ventricular size, and daily drain output |
* Adjust dose based on MIC (target 10-20 times the MIC), ventricular size, and daily drain output |
||
== Duration == |
|||
* CNST or ''P. acnes'': 10 to 14 days |
* CNST or ''P. acnes'': 10 to 14 days |
||
Line 107: | Line 107: | ||
* If repeatedly positive cultures, continued for 10-14 days after the last positive culture |
* If repeatedly positive cultures, continued for 10-14 days after the last positive culture |
||
= Catheter Removal = |
|||
* Shunt removal and EVD placement is recommended for infected CSF shunts |
* Shunt removal and EVD placement is recommended for infected CSF shunts |
||
Line 117: | Line 117: | ||
* Drain or pump removal is recommended for infected drains or pumps |
* Drain or pump removal is recommended for infected drains or pumps |
||
= Monitoring = |
|||
* Response to therapy can be monitored clinically |
* Response to therapy can be monitored clinically |
||
* If there's an EVD, can monitor serial CSF cultures |
* If there's an EVD, can monitor serial CSF cultures |
||
* If no clinical improvement, check CSF again |
* If no clinical improvement, check CSF again |
||
* |
|||
[[Category:IDSA guidelines]] |
|||
[[Category:CNS infections]] |
Revision as of 17:34, 12 August 2019
Healthcare-associated ventriculitis and meningitis (IDSA 2017)
Tunkel AR, Hasbun R, Bhimraj A, Byers K, Kaplan SL, Michael Scheld W, van de Beek D, Bleck TP, Garton HJ, Zunt JR. 2017 Infectious Diseases Society of America's Clinical Practice Guidelines for Healthcare-Associated Ventriculitis and Meningitis. Clin Infect Dis. 2017.
Signs and Symptoms
Ventriculoperitoneal/ventriculopleural shunts
- Headache, nausea, lethargy, or altered mental status
- Erythema and tenderness over the shunt tubing
- Fever without a focus
- Peritonitis or acute abdomen, if peritoneal shunt
- Pleuritis, if pleural shunt
- Bacteremia without focus
- Glomerulonephritis
External ventricular drains (EVD)
- New or worsening mental status
- New fever and increased CSF white cell count
Head trauma
- New headache, fever, meningeal irritation, seizures, or worsening mental status
- Fever without a focus
Intrathecal infusion pumps
- New fever and drainage from the surgical site
CSF Findings
Basic chemistry
- Cell count, glucose, and protein
- May not be reliable
- False positives, and false normals
Cultures
- Culture the CSF! And probably blood (especially if ventriculoatrial)
- If initial cultures are negative, keep growing them for at least 10 days to identify Cutibacterium acnes
- If removing the shunt or drain, send it for culture
- Try to obtain cultures before antibiotics, if safe
Neurosurgery or head trauma
- Elevated cell count, positive culture, and symptoms of infection indicate ventriculitis or meningitis
- Low glucose and high protein suggests ventriculitis or meningitis
- Positive culture is possible to be contaminant if low colony count, normal CSF, no fever
- Multiple organisms in a single sample may be contaminant if no other findings
- Staph. aureus or aerobic gram-negative bacilli indicate infection
- Fungal cultures positive indicate infection
Specific tests
- CSF lactate or procalcitonin may be useful
- Procalcitonin, specifically, may be able to differentiate surgery/hemorrhage from bacterial infection
- NAAT (e.g. PCR) may be helpful
- β-D-glucan and galactomannan may be helpful for fungal infections
Imaging
- MRI with gad and DWI is best
- If VP shunt and abdo symptoms, get abdo US or CT
Antimicrobials
Empiric regimens
- Vanco for gram positives plus anti-pseudomonal beta-lactam (cefipime, ceftazidime, or meropenem) for gram negatives
- Target vanco trough 15-20
- Second-line agents for gram-negative coverage include aztreonam and ciprofloxacin
Specific regimens
- Staphylococci
- MSSA: nafcillin or oxacillin (vanco as second-line) ± rifampin
- MRSA: vanco, unless MIC ≥1, ± rifampin
- Coag-negative Staph: vanco ± rifampin
- If susceptible, consider adding rifampin
- If hardware, recommend rifampin
- If cannot use vanco, then use linezolid, dapto, or TMP-SMX
- P. acnes: penicillin G
- Gram-negatives:
- In general, based on susceptibilities
- Ceftriaxone recommended, if susceptible
- If meropenem, preference for long-infusion (over 3 hours)
- Pseudomonas: cefepime, ceftazidime, or meropenem
- Alternatives include aztreonam or fluoroquinolone
- Acinetobacter: meropenem
- If resistant, colistimethate sodium or polymixin B
- Fungi
- Candida: liposomal ampho B ± 5-flucytosine, stepped down to fluconazole when improved
- Aspergillus and Exserohilum: voriconazole
Intraventricular therapy
- Should be considered if poor response to systemic therapy
- Clamp drain for 15-60 minutes after administration
- Adjust dose based on MIC (target 10-20 times the MIC), ventricular size, and daily drain output
Duration
- CNST or P. acnes: 10 to 14 days
- Staph. aureus and Gram-negatives: 10-14 days, up to 21 days
- If repeatedly positive cultures, continued for 10-14 days after the last positive culture
Catheter Removal
- Shunt removal and EVD placement is recommended for infected CSF shunts
- CNST & P. acnes with normal CSF: reimplant as soon as 3 days if repeat cultures are negative at 48 hours
- CNST & P. acnes with abnormal CSF: after 7 days of antibiotics if repeat cultures are negative
- If repeat cultures are positive, wait for 7-10 days of negative culture before reimplanting
- Staph. aureus and GNBs: reimplant after 10 days of negative cultures
- Don't stop antibiotics to verify clearance of infection before reimplanting
- Drain or pump removal is recommended for infected drains or pumps
Monitoring
- Response to therapy can be monitored clinically
- If there's an EVD, can monitor serial CSF cultures
- If no clinical improvement, check CSF again